As of 2025-12-19, the Relative Valuation of Oric Pharmaceuticals Inc (ORIC) is (19.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.09 USD, the upside of Oric Pharmaceuticals Inc based on Relative Valuation is -344.8%.
The range of the Relative Valuation is (15.01) - (23.20) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 20.3x | 17.2x |
| Forward P/E multiples | 13.1x - 24.7x | 17.4x |
| Fair Price | (15.01) - (23.20) | (19.79) |
| Upside | -285.6% - -386.9% | -344.8% |
| Date | P/E |
| 2025-12-15 | -8.07 |
| 2025-12-12 | -8.20 |
| 2025-12-11 | -8.47 |
| 2025-12-10 | -8.74 |
| 2025-12-09 | -8.86 |
| 2025-12-08 | -9.20 |
| 2025-12-05 | -9.62 |
| 2025-12-04 | -9.96 |
| 2025-12-03 | -9.60 |
| 2025-12-02 | -9.31 |
| 2025-12-01 | -9.75 |
| 2025-11-28 | -10.39 |
| 2025-11-26 | -10.33 |
| 2025-11-25 | -10.16 |
| 2025-11-24 | -10.31 |
| 2025-11-21 | -10.16 |
| 2025-11-20 | -10.04 |
| 2025-11-19 | -10.04 |
| 2025-11-18 | -10.40 |
| 2025-11-17 | -10.54 |
| 2025-11-14 | -10.71 |
| 2025-11-13 | -10.66 |
| 2025-11-12 | -10.91 |
| 2025-11-11 | -11.26 |
| 2025-11-10 | -10.89 |
| 2025-11-07 | -10.80 |
| 2025-11-06 | -10.97 |
| 2025-11-05 | -10.82 |
| 2025-11-04 | -10.75 |
| 2025-11-03 | -11.09 |
| 2025-10-31 | -11.50 |
| 2025-10-30 | -11.66 |
| 2025-10-29 | -11.30 |
| 2025-10-28 | -11.74 |
| 2025-10-27 | -11.71 |
| 2025-10-24 | -11.45 |
| 2025-10-23 | -10.86 |
| 2025-10-22 | -10.56 |
| 2025-10-21 | -11.02 |
| 2025-10-20 | -10.82 |
| 2025-10-17 | -11.17 |
| 2025-10-16 | -11.63 |
| 2025-10-15 | -12.15 |
| 2025-10-14 | -11.50 |
| 2025-10-13 | -12.16 |
| 2025-10-10 | -11.96 |
| 2025-10-09 | -12.31 |
| 2025-10-08 | -12.48 |
| 2025-10-07 | -12.34 |
| 2025-10-06 | -12.60 |